Founded in Boulder, Colorado, AQ BioMed is a privately held biomedical device company with a core mission to innovate biocompatible materials and geometric designs that enhance the effectiveness and longevity of biomedical implants. The company's vision is to revolutionize the way biomedical implants interact with the human body by leveraging new discoveries about cellular responses to chemical interactions and physical forces. AQ BioMed's product offerings span a wide range of technologies, including stents, shunts, artificial organs, and drug delivery devices.
AQ BioMed has attracted notable investors and industry experts due to its pioneering approach in the biomedical field. The company's key achievements include significant advancements in biocompatible material science and the successful development of unique implant designs that have shown promising results in preclinical trials. AQ BioMed's impact is evident in its potential to improve patient outcomes and set new standards in biomedical device performance and safety.
